Actively Recruiting
Enroll-HD A Prospective Registry Study in a Global Huntingtons Disease Cohort
Led by CHDI Foundation, Inc. · Updated on 2024-02-28
35000
Participants Needed
183
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting Enroll-HD, a large, ongoing observational study that combines and expands previous Huntingtons disease HD registries across multiple continents, including Europe, North America, Australasia, and Latin America. This study collects longitudinal clinical data and biological samples from individuals with manifest HD, those carrying or at risk of carrying the HD gene mutation, and control participants without the mutation. The goal is to build a rich database to support research into disease progression, prognosis, and developing clinical trial endpoints. Participants include those with diagnosed HD, pre-manifest carriers, relatives with unknown or negative genotype status, family controls, and community controls. The study involves annual assessments with no planned end date, allowing for long-term data collection. Researchers collect demographic, clinical, family history, genetic, and blood sample information systematically from over 150 sites worldwide. During the study, participants undergo motor, functional, behavioral, and cognitive assessments using standardized tools such as the Unified Huntingtons Disease Rating Scale and Problem Behaviors Assessment-Short. Data are updated at each visit, including clinical signs and genotyping results. The study database is periodically made available to researchers globally, and participants may contribute for many years, helping to advance understanding and support future interventional studies in HD.
CONDITIONS
Brief Title
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals who carry the Huntington's disease gene expansion mutation
- Individuals who do not carry the Huntington's disease expansion mutation (controls)
- Manifest or motor-manifest HD diagnosed by a healthcare provider
- Pre-manifest or motor-manifest HD carriers without diagnostic clinical features
- First or second degree relatives with unknown or negative genotype status
- Family members or unrelated individuals such as spouses or caregivers
- Individuals 18 years of age or older (participants under 18 with juvenile-onset HD may also be eligible)
You will not qualify if you...
- Individuals who do not meet inclusion criteria
- Individuals with choreic movement disorders who test negative for the HD gene mutation
- Community controls with major central nervous system disorders like stroke, Parkinson's disease, or multiple sclerosis
- Participants under 18 years old without juvenile-onset HD
Research Team
N
Noopur Modi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here